Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

Clinical trial NCT06106113 · COMPLETED

Trial details

NCT number: NCT06106113
Sponsor: Fujian Akeylink Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2022-12-15
Primary completion: 2023-02-06
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.